JORDAN BREISCH: Open Payments
NPI 1679241400 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,554 in 104 payments from 38 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $2,554
Food & beverage: $2,310Education: $244
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $287 |
| Incyte Corporation | 7 | $235 |
| Janssen Biotech, Inc. | 14 | $212 |
| Merck Sharp & Dohme LLC | 9 | $172 |
| Aveo Pharmaceuticals, Inc. | 3 | $126 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $117 |
| Lilly USA, LLC | 4 | $116 |
| Novartis Pharmaceuticals Corporation | 5 | $115 |
| GENZYME CORPORATION | 4 | $110 |
| Coherus Oncology, Inc. | 3 | $78 |
Products named: KEYTRUDA, FOTIVDA, VERZENIO, IMFINZI, JAKAFI, AYVAKIT, LOQTORZI, Vonjo.
Industry payments across AZ — which companies pay providers there.
